As reported previously, clinical trial enrollments decreased in the midst of the COVID-19 pandemic, primarily due to concerns about contagion. To examine the attitudes of cancer survivors toward trial participation, Dr Mark Fleury et al surveyed a large group of patients from the American Cancer Society Cancer Action Network’s Survivor Views panel in mid-2020. The […]

During the first 4 months of 2021, Aptitude Health conducted a number of business intelligence CORE meetings with Axess Network community oncologists to gain insights into current practice patterns for managing patients with acute myeloid leukemia (AML). These events are designed to increase understanding of patterns of care, disease-state treatment choices, practice challenges, and resource […]

Disease state academies can be a valuable resource for physicians, as they provide educational resources on therapeutic areas relevant to their practice or specialty. Online academies are designed to benefit all involved, helping to implement standards of care as well as novel therapies in today’s clinical practices. With the field of medicine continually evolving and […]

Immune checkpoint inhibitors have demonstrated efficacy in multiple solid and hematologic malignancies over the past 10 years, and continue to redefine the course of therapy for many patients. They work by helping the immune system recognize and kill foreign targets and overcome the immunosuppressive tumor microenvironment. However, their use may be limited by adverse events […]

Clinical immersion programs are elective courses that offer continuing education for various life science teams as well as practicing clinicians. These programs are traditionally held in a clinical setting and meant to train attendees on a range of topics, including disease state education, competitive landscape, treatment patterns, and expert perspectives in the management of cancer […]